Windtree Therapeutics, Inc.

WINT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$1,787-$20,291-$39,208-$67,636
Dep. & Amort.$84$82$533$192
Deferred Tax-$210$0-$1,367-$9,987
Stock-Based Comp.$455$1,278$3,086$7,238
Change in WC$1,371$2,018-$1,777-$58
Other Non-Cash-$15,315$3,476$19,281$46,587
Operating Cash Flow-$15,402-$13,437-$19,452-$23,664
Investing Activities
PP&E Inv.-$12-$15-$13-$279
Net Acquisitions$0$0$210$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$12-$15$197-$279
Financing Activities
Debt Repay.$1,257-$797-$1,174-$3,872
Stock Issued$5,486$11,549$4,253$27,390
Stock Repurch.$0$0$0$0
Dividends Paid-$657$0$0$0
Other Fin. Act.$6,647$843$0$5,843
Financing Cash Flow$12,733$11,595$3,079$29,361
Forex Effect$0$0$0$0
Net Chg. in Cash-$2,681-$1,857-$16,176$5,418
Supplemental Information
Beg. Cash$4,469$6,326$22,502$17,084
End Cash$1,788$4,469$6,326$22,502
Free Cash Flow-$15,414-$13,452-$19,465-$23,943